Clinical Trial Update: Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of the rotigotine patch in advanced idiopathic Parkinson's disease not well controlled on levodopa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Idiopathic

Drugs mentioned

• Rotigotine patch (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson Disease, Idiopathic | Phase 3 | Status: COMPLETED